Dihydropyridine Calcium Channel Blocker [EPC]

260447 reported adverse events

Drugs of this class: NIFEDIPINE FELODIPINE NIMODIPINE ISRADIPINE NISOLDIPINE AMLODIPINE AND VALSARTAN AMLODIPINE CLEVIDIPINE CLEVIPIDINE FELODIPINE EXTENDED-RELEASE TABLETS OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE TABLET 40/10/25 MG

These side effects are most commonly reported by patients taking drugs of the Dihydropyridine Calcium Channel Blocker [EPC] class:

#	Side effect	Count
0	FATIGUE	14982
1	DYSPNOEA	14161
2	DIARRHOEA	13706
3	NAUSEA	13452
4	DRUG INEFFECTIVE	12216
5	DIZZINESS	11167
6	HEADACHE	10353
7	OFF LABEL USE	9569
8	PAIN	9398
9	ACUTE KIDNEY INJURY	8948

See all common reactions for Dihydropyridine Calcium Channel Blocker [EPC]

Drugs of the Dihydropyridine Calcium Channel Blocker [EPC] class are most commonly taken among patients reporting these side effects:

#	Side effect	Count	Frequency
0	CARDIOSPASM	258	0.6701
1	IMMUNISATION	173	0.5786
2	PALMOPLANTAR KERATODERMA	253	0.4884
3	NON-CARDIOGENIC PULMONARY OEDEMA	237	0.3395
4	GINGIVAL HYPERTROPHY	336	0.3134
5	HYPERPARATHYROIDISM SECONDARY	663	0.2847
6	CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER	284	0.2823
7	DISTRIBUTIVE SHOCK	267	0.2822
8	VASOPLEGIA SYNDROME	288	0.2756
9	NEPHROGENIC ANAEMIA	1184	0.2697

See all enriched reactions for Dihydropyridine Calcium Channel Blocker [EPC]